NeuroPace, Inc. (NPCE)
8.22
+0.25
(+3.14%)
USD |
NASDAQ |
Nov 17, 16:00
8.35
+0.13
(+1.58%)
After-Hours: 20:00
NeuroPace Price to Book Value : 24.63 for Nov. 17, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 23.88 |
| November 13, 2026 | 22.65 |
| November 12, 2026 | 36.01 |
| November 11, 2026 | 37.51 |
| November 10, 2026 | 38.02 |
| November 09, 2026 | 39.31 |
| November 06, 2026 | 37.45 |
| November 05, 2026 | 38.02 |
| November 04, 2026 | 39.97 |
| November 03, 2026 | 36.88 |
| November 02, 2026 | 36.97 |
| October 30, 2026 | 36.85 |
| October 29, 2026 | 38.98 |
| October 28, 2026 | 38.74 |
| October 27, 2026 | 39.01 |
| October 26, 2026 | 38.92 |
| October 23, 2026 | 38.68 |
| October 22, 2026 | 39.37 |
| October 21, 2026 | 39.10 |
| October 20, 2026 | 40.48 |
| October 19, 2026 | 38.26 |
| October 16, 2026 | 36.67 |
| October 15, 2026 | 38.29 |
| October 14, 2026 | 37.63 |
| October 13, 2026 | 37.99 |
| Date | Value |
|---|---|
| October 12, 2026 | 38.95 |
| October 09, 2026 | 37.96 |
| October 08, 2026 | 37.12 |
| October 07, 2026 | 38.23 |
| October 06, 2026 | 37.96 |
| October 05, 2026 | 39.61 |
| October 02, 2026 | 38.05 |
| October 01, 2026 | 39.40 |
| September 30, 2026 | 41.23 |
| September 29, 2026 | 40.22 |
| September 28, 2026 | 40.82 |
| September 25, 2026 | 40.56 |
| September 24, 2026 | 40.30 |
| September 23, 2026 | 41.00 |
| September 22, 2026 | 42.44 |
| September 21, 2026 | 41.95 |
| September 18, 2026 | 41.20 |
| September 17, 2026 | 40.82 |
| September 16, 2026 | 40.68 |
| September 15, 2026 | 41.11 |
| September 14, 2026 | 42.09 |
| September 11, 2026 | 40.51 |
| September 10, 2026 | 40.02 |
| September 09, 2026 | 41.83 |
| September 08, 2026 | 42.58 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tandem Diabetes Care, Inc. | 8.789 |
| Accuray, Inc. | 0.1351 |
| Orthofix Medical, Inc. | 0.6337 |
| ResMed, Inc. | 5.630 |
| Rockwell Medical, Inc. | 0.7971 |
Price to Book Value Related Metrics
| PS Ratio | 2.945 |
| Price | 8.22 |
| Earnings Yield | -6.79% |
| Market Cap | 283.03M |